Short Sleep Duration Linked to All-Cause Mortality in Apnea Patients
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 5, 2023 -- For patients with obstructive sleep apnea (OSA), those sleeping less than seven hours have increased risk of all-cause mortality, according to a study published online Dec. 5 in JAMA Network Open.
Yiqi Lin, M.D., from Fujian Medical University in Fuzhou, China, and colleagues conducted a cohort study to examine whether there is an association between sleep duration and all-cause mortality among participants with OSA. Data were included for 2,574 individuals with OSA defined by apnea-hypopnea index (AHI) ≥15.
A total of 688 all-cause deaths were observed among the participants. The researchers found that the groups sleeping six to less than seven hours, five to less than six hours, and less than five hours had significantly higher risks of all-cause mortality, independent of AHI, compared with the group sleeping at least seven hours (hazard ratios, 1.53, 1.40, and 1.64, respectively). The finding was mainly consistent in sensitivity analyses performed among participants with available data of positive airway pressure treatment during follow-up.
"Further research would be needed to shed light on its underlying mechanism and possible health benefits of extending sleep length among people with OSA with short sleep duration by sleep education or other sleep intervention," the authors write.
One author disclosed ties to Eisai China Inc.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Sleep Apnea, Low Oxygen in Sleep Linked to Late-Onset Epilepsy
THURSDAY, May 2, 2024 -- Sleep apnea and late-midlife oxygen desaturation to less than 80 percent during sleep are associated with subsequent development of late-onset epilepsy...
Hypoglossal Nerve Stimulation Aids Obstructive Sleep Apnea
THURSDAY, April 18, 2024 -- Hypoglossal nerve stimulation (HGNS) helps to reduce obstructive sleep apnea (OSA) but has a decreased response in some patients, according to a study...
Eli Lilly Says Zepbound Can Ease Obstructive Sleep Apnea
WEDNESDAY, April 17, 2024 -- Eli Lilly announced Wednesday that in two company trials, Zepbound was found to ease sleep apnea in adults with obesity. First approved to treat...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.